RxDoctor Payments Data

Gopal Badlani, MD

Urology · Winston Salem, NCNPI 1811930365

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,004 of the $25,340 with a category attached, or 86.8%. 14 manufacturers reported payments, led by Teleflex LLC at 41.4% of the total. Reporting peaked in 2019 at $5,649 and has fallen 98.7% since, to $71 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,340in general payments, 2019–2025

Across 29 payments — averaging $873.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$10K
  • Neotract Inc.$9K
  • Caldera Medical, Inc$4K
  • Coloplast$1K
  • Olympus Corporation$540
  • Olympus America Inc.$186
  • plus $351 from 8 others
$90,075in research payments, 2019–2025

Across 31 payments — averaging $2905.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Procept Biorobotics Corporation$58K
  • Boston Scientific$27K
  • Olympus Corporation Of The Americas$6K

What the payments were for

  • Consulting fees$22,00487%
  • Speaking & faculty fees$5402%
  • Travel & lodging$1,9238%
  • Food & beverage$8733%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,340 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina

Medicare billing

Part B allowed, 2024
$48,544
Medicare patients
127
Services billed
2,180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron67$39,938
Tamsulosin Hcl97$1,340
Oxybutynin Chloride ErOxybutynin Chloride66$845
Finasteride65$511
Testosterone Cypionate13$295
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$265
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$208
Solifenacin Succinate13$205

Paid to pharmacies, not to this prescriber.

Other urology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →